AFGVF logo

Agfa-Gevaert N.V. (AFGVF) Análisis de Acciones

Solo con fines informativos. No es asesoramiento financiero. Analysis by Sedat Aydin, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.

AFGVF representa a Agfa-Gevaert N.V., una empresa del sector Industrials con un precio de $ (capitalización de mercado 0). Calificado con 42/100 (cauteloso) en potencial de crecimiento, salud financiera e impulso.

Ultimo analisis: 16 mar 2026
Puntuación de IA de 42/100

Perfil de Operaciones Industriales de Agfa-Gevaert N.V. (AFGVF)

CEOPascal Juery
Empleados4765
Sede CentralMortsel, BE
Año de la oferta pública inicial (OPI)2009

Agfa-Gevaert NV, founded in 1867, provides imaging solutions and IT services across diverse sectors, including printing, healthcare, and industrial applications. With a global reach and a focus on both analog and digital technologies, the company caters to specialized needs in hospitals, printing companies, and industrial manufacturers.

Procedencia de los datos | Datos financieros Análisis cuantitativo NASDAQ Análisis: 16 mar 2026

Tesis de Inversión

Agfa-Gevaert NV presents a complex investment case. The company's diverse portfolio across imaging and IT solutions offers exposure to multiple sectors, including healthcare and printing. However, its negative P/E ratio of -1.00 and a negative profit margin of -6.4% indicate profitability challenges. The company's beta of 0.58 suggests lower volatility compared to the market. Growth catalysts include expansion in the digital printing and healthcare IT segments. Investors should carefully consider the company's financial performance and competitive positioning before making investment decisions.

Basado en las finanzas de FMP y el análisis cuantitativo

Puntos clave

  • Market capitalization of $0.09 billion reflects its current valuation in the market.
  • Negative P/E ratio of -1.00 indicates the company is currently not profitable.
  • Gross margin of 30.1% shows the percentage of revenue exceeding the cost of goods sold.
  • Beta of 0.58 suggests the stock is less volatile than the overall market.
  • The company operates in four segments: Offset Solutions, Radiology Solutions, Healthcare IT, and Digital Print & Chemicals.

Competidores y Pares

Fortalezas

  • Diverse product portfolio across multiple segments.
  • Global sales and distribution network.
  • Expertise in both analog and digital technologies.
  • Established brand reputation in the imaging industry.

Debilidades

  • Negative profitability and P/E ratio.
  • Exposure to cyclical industries, such as printing.
  • Competition from larger and more diversified companies.
  • Dependence on specific markets and customers.

Catalizadores

  • Ongoing: Expansion in the healthcare IT market, driven by the increasing adoption of digital solutions in healthcare.
  • Ongoing: Growth in the digital printing market, fueled by the demand for customized and short-run printing.
  • Upcoming: Potential partnerships with hydrogen technology companies to develop membranes for hydrogen production.
  • Ongoing: Focus on product innovation and expansion in specialty films and materials.
  • Ongoing: Geographic expansion in emerging markets to increase global reach and revenue.

Riesgos

  • Potential: Technological obsolescence in the imaging industry.
  • Potential: Economic downturns affecting demand for printing and industrial products.
  • Ongoing: Increased competition from larger and more diversified companies.
  • Potential: Regulatory changes impacting the healthcare and printing industries.
  • Ongoing: Negative profitability and P/E ratio indicating financial challenges.

Oportunidades de crecimiento

  • Expansion in Healthcare IT Solutions: Agfa-Gevaert can capitalize on the growing demand for healthcare IT solutions, including picture archiving and communication systems (PACS) and hospital information systems (HIS). The global healthcare IT market is projected to reach $440.2 billion by 2026, offering significant growth potential. By focusing on integrated care solutions and expanding its customer base in hospitals and imaging centers, Agfa-Gevaert can increase its market share and revenue.
  • Growth in Digital Printing and Industrial Inks: The digital printing market is expanding rapidly, driven by the increasing demand for customized and short-run printing. Agfa-Gevaert's Digital Print & Chemicals segment can benefit from this trend by offering inkjet printers, inks, and fluids for various industrial applications. The global digital printing market is expected to reach $40.8 billion by 2026. By developing innovative ink formulations and expanding its product portfolio, Agfa-Gevaert can strengthen its position in this market.
  • Development of Hydrogen Production Membranes: Agfa-Gevaert's expertise in membrane technology can be leveraged to develop membranes for hydrogen production. The demand for hydrogen as a clean energy source is increasing, driving the need for efficient and cost-effective hydrogen production methods. The global hydrogen generation market is projected to reach $201 billion by 2030. By investing in research and development and partnering with hydrogen technology companies, Agfa-Gevaert can tap into this emerging market.
  • Focus on Specialty Films and Materials: Agfa-Gevaert's Digital Print & Chemicals segment offers specialty films for various applications, including micrography, non-destructive testing, and security documents. These films cater to niche markets with specific requirements. By focusing on product innovation and expanding its customer base in these markets, Agfa-Gevaert can generate stable revenue streams and improve its profitability.
  • Geographic Expansion in Emerging Markets: Agfa-Gevaert can expand its presence in emerging markets, where the demand for imaging solutions and IT services is growing rapidly. By establishing partnerships with local distributors and tailoring its products to meet the specific needs of these markets, Agfa-Gevaert can increase its global reach and revenue. Emerging markets offer significant growth opportunities due to their increasing healthcare spending and industrial development.

Oportunidades

  • Expansion in healthcare IT solutions.
  • Growth in digital printing and industrial inks.
  • Development of hydrogen production membranes.
  • Geographic expansion in emerging markets.

Amenazas

  • Technological obsolescence.
  • Economic downturns.
  • Increased competition.
  • Regulatory changes.

Ventajas competitivas

  • Established brand reputation in the imaging industry.
  • Extensive product portfolio across multiple segments.
  • Global sales and distribution network.
  • Expertise in both analog and digital technologies.

Acerca de AFGVF

Agfa-Gevaert NV, established in 1867 and headquartered in Mortsel, Belgium, has evolved from a manufacturer of photographic materials to a provider of comprehensive imaging solutions and IT services. The company operates through four primary segments: Offset Solutions, Radiology Solutions, Healthcare IT, and Digital Print & Chemicals. The Offset Solutions segment offers integrated prepress and printing solutions, including computer-to-plate systems, pressroom supplies, and workflow software. The Radiology Solutions segment provides analog and digital imaging technologies for diagnostic purposes, including X-ray film, digital radiography equipment, and image processing software. The Healthcare IT segment delivers picture archiving and communication systems, hospital information systems, and integrated care solutions. The Digital Print & Chemicals segment focuses on inkjet printers, inks, and fluids for various industrial applications, as well as specialty films and materials. Agfa-Gevaert sells its products through its own sales organization and a network of agents and representatives worldwide.

Qué hacen

  • Develops and distributes analog and digital imaging systems.
  • Provides IT solutions for healthcare and industrial applications.
  • Offers integrated prepress and printing solutions for commercial, newspaper, and packaging printers.
  • Supplies X-ray film, hardcopy film, and digital radiography equipment for diagnostic imaging.
  • Delivers picture archiving and communication systems (PACS) for hospitals and imaging centers.
  • Produces inkjet printers, inks, and fluids for industrial inkjet applications.
  • Manufactures specialty films for micrography, non-destructive testing, and security documents.

Modelo de Negocio

  • Develops and sells imaging hardware and software solutions.
  • Provides IT services and support to healthcare providers.
  • Generates revenue through sales of consumables, such as film and ink.
  • Offers maintenance and service contracts for its equipment.

Contexto de la Industria

Agfa-Gevaert NV operates in the industrial machinery sector, which is influenced by technological advancements and economic cycles. The company faces competition from established players and new entrants in each of its segments. The healthcare IT market is experiencing growth due to the increasing adoption of digital solutions in healthcare. The printing industry is evolving with the shift towards digital printing technologies. Agfa-Gevaert's ability to innovate and adapt to these trends will be crucial for its success.

Clientes Clave

  • Commercial, newspaper, and packaging printers.
  • Hospitals and imaging centers.
  • Sign and display printing companies.
  • Industrial manufacturers using inkjet printing.
  • Organizations requiring specialty films for security documents and print media.
Confianza de la IA: 71% Actualizado: 16 mar 2026

Finanzas

Gráfico e información

Precio de la acción de Agfa-Gevaert N.V. (AFGVF): Price data unavailable

Últimas noticias

No hay noticias recientes disponibles para AFGVF.

Consenso de analistas

Calificación de Consenso

Recomendaciones agregadas de Compra/Mantener/Vender de Benzinga, Yahoo Finance y Finnhub para AFGVF.

Objetivos de Precios

Análisis del precio objetivo de Wall Street para AFGVF.

MoonshotScore

42/100

¿Qué significa esta puntuación?

El MoonshotScore califica el potencial de crecimiento de AFGVF en una escala de 0 a 100 en múltiples factores, incluyendo innovación, disrupción del mercado, salud financiera e impulso.

Liderazgo: Pascal Juery

CEO

Pascal Juery has served as the CEO of Agfa-Gevaert since 2015. Prior to joining Agfa-Gevaert, he held various leadership positions at Rhodia and Solvay, where he gained extensive experience in the chemical and materials industries. He holds a degree in Chemical Engineering from École Polytechnique and an MBA from INSEAD.

Historial: Under Pascal Juery's leadership, Agfa-Gevaert has focused on transforming its business model and investing in growth areas, such as healthcare IT and digital printing. He has overseen the company's efforts to streamline its operations, reduce costs, and improve its financial performance. Key milestones include the acquisition of several healthcare IT companies and the launch of new digital printing products.

Información del mercado OTC de AFGVF

The OTC Other tier represents the lowest tier of the OTC market, indicating that Agfa-Gevaert N.V. may not meet the minimum financial standards or reporting requirements of higher tiers like OTCQX or OTCQB. Companies in this tier may have limited financial disclosure, making it more difficult for investors to assess their financial health and performance. Investing in OTC Other stocks carries higher risks compared to stocks listed on major exchanges due to the lack of regulatory oversight and transparency.

  • Nivel OTC: OTC Other
  • Estado de divulgación: Unknown
Liquidez: Liquidity for AFGVF is likely limited given its OTC Other listing. Expect wider bid-ask spreads compared to major exchanges, potentially leading to higher transaction costs. Lower trading volumes may make it difficult to buy or sell large quantities of shares without significantly impacting the price. Investors should exercise caution and use limit orders to manage potential price slippage.
Factores de riesgo OTC:
  • Limited financial disclosure increases information asymmetry.
  • Lower liquidity can lead to price volatility.
  • Higher potential for fraud and manipulation.
  • OTC Other stocks may be subject to less regulatory oversight.
  • Delisting risk if the company fails to meet minimum requirements.
Lista de verificación de diligencia debida:
  • Verify the company's financial statements and audit reports.
  • Research the background and experience of the company's management team.
  • Assess the company's business model and competitive landscape.
  • Review the company's legal and regulatory filings.
  • Check for any history of fraud or misconduct.
  • Understand the risks associated with investing in OTC stocks.
  • Consult with a qualified financial advisor.
Señales de legitimidad:
  • Company has been in operation since 1867.
  • Presence in multiple segments: Offset Solutions, Radiology Solutions, Healthcare IT, and Digital Print & Chemicals.
  • Global sales and distribution network.
  • CEO with prior experience at Rhodia and Solvay.
  • The company has a substantial number of employees (4765).

AFGVF Preguntas Frecuentes sobre Acciones de Industrials

¿Cuáles son los factores clave para evaluar AFGVF?

Agfa-Gevaert N.V. (AFGVF) actualmente tiene una puntuación IA de 42/100, indicando puntuación baja. Fortaleza clave: Diverse product portfolio across multiple segments.. Riesgo principal a monitorear: Potential: Technological obsolescence in the imaging industry.. Esto no es asesoramiento financiero.

¿Qué es el MoonshotScore de AFGVF?

AFGVF actualmente puntúa 42/100 (Grado D) en el MoonshotScore, lo que sugiere calificación baja. La puntuación evalúa el potencial de crecimiento, la salud financiera, el impulso del mercado y los factores de riesgo en 9 KPIs cuantitativos. Se recalcula diariamente con los últimos datos del mercado. Esta puntuación es solo informativa.

¿Con qué frecuencia se actualizan los datos de AFGVF?

Los precios de AFGVF se actualizan en tiempo real durante el horario del mercado estadounidense (9:30-16:00 ET, días laborables). Los fundamentales se actualizan después de los informes trimestrales o anuales. Las calificaciones de analistas y las perspectivas de IA se actualizan diariamente. Las noticias se agregan continuamente de fuentes financieras.

¿Qué dicen los analistas sobre AFGVF?

La cobertura de analistas para AFGVF incluye calificaciones de consenso (compra, mantener, venta), objetivos de precio a 12 meses y estimaciones de ganancias de las principales firmas de investigación. Consulte la sección de Consenso de Analistas en esta página.

¿Cuáles son los riesgos de invertir en AFGVF?

Las categorías de riesgo para AFGVF incluyen riesgo de mercado, riesgo específico de la empresa (gestión, competencia), riesgo financiero (deuda, consumo de efectivo) y riesgo macroeconómico (tasas, inflación). Un riesgo clave identificado: Potential: Technological obsolescence in the imaging industry.. Un beta superior a 1,0 indica mayor volatilidad que el S&P 500. Revise la sección de Factores de Riesgo en esta página. Todas las inversiones conllevan riesgo de pérdida.

¿Cuál es la relación P/E de AFGVF?

La relación P/E para AFGVF compara el precio actual de la acción con sus ganancias por acción. Un P/E más alto puede indicar expectativas de crecimiento, mientras que un P/E más bajo puede sugerir valor. Consulte la pestaña de Financieros para métricas actuales.

¿Está AFGVF sobrevalorada o infravalorada?

Determinar si Agfa-Gevaert N.V. (AFGVF) está sobrevalorada o infravalorada requiere examinar múltiples métricas. Compare los ratios de valoración (P/E, P/S, EV/EBITDA) con pares del sector. Esto no es asesoramiento financiero.

¿Cuál es el rendimiento por dividendo de AFGVF?

Agfa-Gevaert N.V. (AFGVF) actualmente no paga un dividendo regular, o los datos de rendimiento no están disponibles. Consulte la pestaña de Financieros para información actual.

Descargo de responsabilidad: Este contenido es solo para fines informativos y no constituye asesoramiento de inversión. Siempre haga su propia investigación y consulte a un asesor financiero.

Recursos Oficiales

Análisis actualizado el Puntuación de IA actualizada diariamente
Fuentes de Datos y Metodología
Datos de mercado proporcionados por Financial Modeling Prep y Yahoo Finance. Análisis de IA por algoritmos propietarios de Stock Expert AI. Indicadores técnicos mediante cálculos estándar de la industria. Última actualización: .

Datos proporcionados solo con fines informativos.

Notas de análisis
  • OTC data may have limited availability and reliability.
  • AI analysis pending for AFGVF.
Fuentes de datos

Popular Stocks